LSD-Assisted Therapy for 12 People with Anxiety Related to Life-Threatening Illness

Investigator: Peter Gasser MD
Sponsor: MAPS
Contact: Peter Gasser, MD
This research will study the safety and efficacy of LSD-assisted psychotherapy in reducing anxiety arising from diagnosis with a serious illness and limited life expectancy, to be conducted in 12 subjects in Switzerland by Dr. Peter Gasser. The protocol was reviewed and approved by the ethics board and was reviewed and cleared by Swissmedic, the Swiss Food and Drug Agency, and has been reviewed and cleared by BAG, the agency akin to the US Drug Enforcement Administration. Dr. Gasser sent in his first annual report on November 25, 2008 and has enrolled four subjects.